Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01284
|
|||||
| Drug Name |
Trospium chloride
|
|||||
| Synonyms |
trospium chloride; Sanctura; Trospium (chloride); Spasmex; Spasmo-lyt; UNII-1E6682427E; Trospium chloride (Sanctura); Relaspium; Santura; Keptan; Azoniaspiro Compound XVII; Spasmo 3; IP631; AS Xvii; 1E6682427E; DSSTox_CID_3724; DSSTox_RID_77166; DSSTox_GSID_23724; Trospii chloridum [INN-Latin]; Uraplex; Cloruro de trospio [INN-Spanish]; Chlorure de trospium [INN-French]; EINECS 233-875-4; Trospium Cl; Trospii chloridum; Sanctura XR; Cloruro de trospio
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Overactive bladder [ICD11: GC50.0] | Approved | [1] | |||
| Therapeutic Class |
Respiratory Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C25H30ClNO3
|
|||||
| Canonical SMILES |
C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]
|
|||||
| InChI |
InChI=1S/C25H30NO3.ClH/c27-24(25(28,19-9-3-1-4-10-19)20-11-5-2-6-12-20)29-23-17-21-13-14-22(18-23)26(21)15-7-8-16-26;/h1-6,9-12,21-23,28H,7-8,13-18H2;1H/q+1;/p-1/t21-,22+,23?;
|
|||||
| InChIKey |
RVCSYOQWLPPAOA-DHWZJIOFSA-M
|
|||||
| CAS Number |
CAS 10405-02-4
|
|||||
| Pharmaceutical Properties | Molecular Weight | 428 | Topological Polar Surface Area | 46.5 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP1A2 | Transporter Info | Organic anion transporting polypeptide 1A2 | Substrate | [2] | |
| OCT-1 | Transporter Info | Organic cation transporter 1 | Substrate | [2] | ||
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | ||
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | OATP1A2 | Transporter Info | Km = 34.9 microM | Primary human bladder urothelium cells (HBU) | [2] | |
| OCT-1 | Transporter Info | Km = 106 microM | Primary human bladder urothelium cells (HBU) | [2] | ||
| P-GP | Transporter Info | Km = 6.9 microM | Primary human bladder urothelium cells (HBU) | [2] | ||
| References | ||||||
| 1 | Trospium chloride was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics. Mol Pharm. 2015 Jan 5;12(1):171-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.